
News|Articles|May 1, 2007
Pipeline preview
The latest FDA action (through May 2007) related to armodafinil (Nuvigil), tacrolimus (Prograf), sipuleucel-T (Provenge), Etoricoxib (Arcoxia), AZD-103/ELND005 (Transition), rNAPc2, Satraplatin, and Ganciclovir
Advertisement
Key Points
• Pipeline preview
Approvable designations
Recommendation for approval
Fast-track designations
Priority review
Orphan drug designation
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
HS patients on biosimilar adalimumab lose response faster than those on the original drug
2
CMS negotiates a 70% discount for Ozempic and Wegovy
3
Global MS analysis links disability burden to rising economic strain
4
New drug class shows promise for geographic atrophy
5






















































